Stock Analysis
- China
- /
- Healthtech
- /
- SZSE:300451
3 Growth Companies With High Insider Ownership Achieving 66% Earnings Growth
Reviewed by Simply Wall St
In a week marked by volatility and mixed performances across global markets, the U.S. saw tech stocks stumble amid new competition fears while European indices hit record highs following interest rate cuts. The Federal Reserve's decision to hold rates steady amidst ongoing inflation concerns has kept investors on edge, highlighting the importance of identifying growth companies with strong fundamentals, such as high insider ownership and robust earnings growth, which can offer stability in uncertain times.
Top 10 Growth Companies With High Insider Ownership
Name | Insider Ownership | Earnings Growth |
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) | 17.3% | 20.5% |
Clinuvel Pharmaceuticals (ASX:CUV) | 10.4% | 26.2% |
SKS Technologies Group (ASX:SKS) | 29.7% | 24.8% |
Propel Holdings (TSX:PRL) | 36.5% | 38.9% |
On Holding (NYSE:ONON) | 19.1% | 29.7% |
Pharma Mar (BME:PHM) | 11.9% | 44.7% |
Kingstone Companies (NasdaqCM:KINS) | 20.8% | 24.9% |
Brightstar Resources (ASX:BTR) | 16.2% | 86% |
Elliptic Laboratories (OB:ELABS) | 26.8% | 121.1% |
Findi (ASX:FND) | 35.8% | 110.7% |
Underneath we present a selection of stocks filtered out by our screen.
Jolywood (Suzhou) SunwattLtd (SZSE:300393)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Jolywood (Suzhou) Sunwatt Co., Ltd. manufactures and sells integrated photovoltaic (PV) products worldwide, with a market cap of CN¥6.11 billion.
Operations: The company's revenue is primarily derived from the Photovoltaic Industry, amounting to CN¥7.06 billion.
Insider Ownership: 19.4%
Earnings Growth Forecast: 64.6% p.a.
Jolywood (Suzhou) Sunwatt Ltd. is trading at a substantial discount, 78.4% below its estimated fair value, suggesting potential upside. Despite having a high debt level and an unsustainable dividend yield of 2.46%, the company is expected to experience significant growth with revenue forecasted to increase by 26.5% annually, outpacing the market average of 13.3%. Earnings are projected to grow by 64.65% per year, becoming profitable within three years.
- Click to explore a detailed breakdown of our findings in Jolywood (Suzhou) SunwattLtd's earnings growth report.
- According our valuation report, there's an indication that Jolywood (Suzhou) SunwattLtd's share price might be on the cheaper side.
Boji Medical TechnologyLtd (SZSE:300404)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Boji Medical Technology Co., Ltd. offers professional contract research services for the research, development, and production of drugs and medical devices to pharmaceutical companies both in China and internationally, with a market cap of CN¥3.17 billion.
Operations: Revenue Segments (in millions of CN¥):
Insider Ownership: 39.2%
Earnings Growth Forecast: 40.3% p.a.
Boji Medical Technology Ltd. is poised for substantial growth, with revenue forecasted to rise by 23.3% annually, surpassing the CN market average of 13.3%. Earnings are expected to grow significantly at 40.27% per year, outpacing the market's 25.1%. Despite impressive past earnings growth of 52.3%, future returns may be tempered by a projected low return on equity of 10% in three years and large one-off items affecting earnings quality.
- Dive into the specifics of Boji Medical TechnologyLtd here with our thorough growth forecast report.
- Upon reviewing our latest valuation report, Boji Medical TechnologyLtd's share price might be too optimistic.
B-SOFTLtd (SZSE:300451)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: B-SOFT Co., Ltd. operates in the medical and health informatization industry in China, with a market cap of CN¥6.27 billion.
Operations: B-SOFT Co., Ltd. generates its revenue from the medical and health informatization sector within China.
Insider Ownership: 15.7%
Earnings Growth Forecast: 66.6% p.a.
B-SOFT Ltd. is forecast to achieve profitability within three years, with earnings expected to grow significantly at 66.63% annually, outpacing the CN market's average growth rate of 13.3%. However, its projected return on equity is relatively low at 6.4% in three years, and revenue growth is anticipated to be moderate at 16.5% per year. There has been no substantial insider trading activity over the past three months, indicating stable insider sentiment.
- Get an in-depth perspective on B-SOFTLtd's performance by reading our analyst estimates report here.
- Our valuation report unveils the possibility B-SOFTLtd's shares may be trading at a premium.
Where To Now?
- Click here to access our complete index of 1477 Fast Growing Companies With High Insider Ownership.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if B-SOFTLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:300451
B-SOFTLtd
Operates in the medical and health informatization industry in China.